Bupropion Hydrochloride (SR) 150 mg Tablet, Extended Release, 90-count
by Macleods Pharmaceuticals Limited · 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (33342-527-10)
NDC 33342-0527-10
🏷️ FDA NDC (as labeled)
33342-527-10
billing pads the product segment with a zero
This package
Contains90-count
Pack sizes3 compare ↓
Rx only
Generic
On market
Non-controlled
🗂️ Data synced Sep 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
⚠️
Other active recalls for Bupropion Hydrochloride (different manufacturers) — 3 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Sep 15, 2025 — Failed Tablet/Capsule Specifications (Graviti Pharmaceuticals Private Limited) · FDA recall D-0037-2026
Class II · Jun 24, 2024 — Failed Dissolution Specifications; the product is dissolving faster than the specified limits. (Amerisource Health Services LLC) · FDA recall D-0590-2024
Class II · Dec 29, 2023 — Presence of Foreign Tablets/Capsules (Rising Pharma Holding, Inc.) · FDA recall D-0222-2024
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗
🆔 Identity & classification
FDA NDC (as labeled)
33342-527-10
Product NDC
33342-527
11-digit billing NDC
33342052710
Application #
ANDA218567
SPL Set ID
6127b24e-261c-4b64-8423-ebe583676abe
Established class (EPC)
Aminoketone
Mechanism of action
Dopamine Uptake Inhibitors; Norepinephrine Uptake Inhibitors
Physiologic effect
Increased Dopamine Activity; Increased Norepinephrine Activity
DEA schedule
Non-controlled
Marketing category
ANDA
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2026-06-23
Route
ORAL
Dosage form
TABLET, EXTENDED RELEASE
Substance
BUPROPION HYDROCHLORIDE
TE code (Orange Book)
AB1 · RLD · RS
Why two NDCs?
The FDA registers this code as 33342-527-10 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 33342-0527-10. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
🏭 Manufacturer & labeler
LabelerMacleods Pharmaceuticals Limited
Application holderMACLEODS PHARMACEUTICALS LTD
FDA applicationANDA218567 (ANDA)
Labeler code33342
First marketedJun 2026
Product typeHuman Prescription Drug
Portfolio389 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
🩺 Clinical
📗 Our plain-language guide HelloPharmacist
- Bupropion is an antidepressant primarily used to treat major depressive disorder — that's clinical depression. Depending on which formulation you're prescribed, it may also be used...
- Most people don't notice a full effect immediately — antidepressant treatment for depression typically requires several months or longer. Your dose may also be increased gradually...
- Will bupropion make me feel better right away?
- The most common ones are dry mouth, nausea, trouble sleeping, dizziness, headache, and feeling anxious or agitated — especially early on. Many of these improve as your body adjusts...
Patient education
Supplement & herbal interactions
1
Nutrient depletion considerations
Bupropion may be associated with lower levels of 1 nutrient — worth a chat with your pharmacist, not a cause for alarm.
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
💬 Questions about Bupropion Hydrochloride?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
💊 What it looks like
Color
Blue / Purple / Pink
ShapeRound
ImprintT47
Size12 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.
🧪 Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII OP1R32D61U
Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
-
UNII ZT934N0X4W
A naturally occurring amino acid salt used as a reducing agent and antioxidant in medications. It helps prevent ingredient breakdown and may improve product stability during storage.
-
UNII 7Z8S9VYZ4B
Ethylcellulose is a plant-derived thickener and film-former made by chemically modifying cellulose. It's used as a binder to hold tablet ingredients together, a coating to control how quickly medicine is released, or a thickener in liquid formulations.
-
UNII L06K8R7DQK
A synthetic blue dye approved by the FDA for use in medications and foods. It serves as a colorant to make pills and liquids visually distinct and easier to identify.
-
UNII WZB9127XOA
A synthetic red dye used to color medications and make them easier to identify. It serves as a colorant in tablets, capsules, and liquid formulations.
-
UNII RN3152OP35
Hypromellose is a plant-based thickener and film-former derived from cellulose. In medicines, it's used to create coatings on tablets and capsules, control how fast the drug dissolves, and improve the product's texture and stability.
-
UNII R75537T0T4
Hypromellose 2910 is a plant-derived thickening agent made from cellulose. It serves as a binder that holds tablet ingredients together, a film-coating for pills, and a viscosity controller in liquids.
-
UNII 70097M6I30
Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
-
UNII 532B59J990
Polyvinyl alcohol is a synthetic polymer made from plant-derived materials. It's used as a binder to hold ingredients together, a film-former in coatings, and a thickener in liquid formulations.
-
UNII 7SEV7J4R1U
A powder made from a naturally occurring mineral. In medicines, talc works as a glidant and anti-caking agent, helping tablets and capsules flow smoothly during manufacturing and preventing clumping.
-
UNII 15FIX9V2JP
Titanium dioxide is a bright white mineral powder commonly used as a colorant and opacifying agent. It makes pills and tablets white or lighter in color and helps make coatings non-transparent.
11 inactive ingredients listed in the exact product block matched to this NDC.
Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed —
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
💲 Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per each | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
🔁 Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Bupropion Hydrochloride 150 mg 68001-0519-03 | BluePoint | 500 tablets | $0.077 | AB3 | Availability likely | — |
| Bupropion Hydrochloride (XL) 150 mg 24979-0101-02 | Upsher-Smith | 500 tablets | $0.078 | — | Discontinued | — |
| Bupropion Hydrochloride 150 mg 69097-0071-12 | Cipla | 500 tablets | $0.078 | AB3 | Availability likely | — |
| Bupropion Hydrochloride XL 150 mg 00591-3331-05 | Actavis | 500 tablets | $0.078 | AB3 | Availability likely | — |
| Bupropion hydrochloride 150 mg 70010-0784-03 | Granules | 30 tablets | $0.078 | AB3 | Availability likely | — |
| Bupropion Hydrochloride XL 150 mg 00904-7505-04 | Major | 1 tablet | $0.078 | AB3 | Availability likely | — |
| bupropion hydrochloride 150 mg 16571-0862-03 | Rising | 30 tablets | $0.078 | AB3 | Availability likely | — |
| Bupropion Hydrochloride XL 150 mg 69367-0288-05 | Westminster | 500 tablets | $0.078 | AB3 | Discontinued | — |
| Bupropion Hydrochloride 150 mg 31722-0487-05 | Camber | 500 tablets | $0.078 | AB3 | Availability likely | — |
| Bupropion Hydrochloride XL 150 mg 42806-0414-05 | Epic | 500 tablets | $0.078 | AB3 | Availability likely | — |
| Bupropion Hydrochloride 150 mg 50268-0133-13 | AvPAK | 1 tablet | $0.078 | AB3 | Availability likely | — |
| Bupropion Hydrochloride (XL) 150 mg 50228-0144-05 | ScieGen | 500 tablets | $0.078 | AB3 | Availability likely | — |
| Bupropion Hydrochloride XL 150 mg 68180-0319-02 | Lupin | 500 tablets | $0.078 | AB3 | Availability likely | — |
| Bupropion Hydrochloride 150 mg 60687-0782-01 | American | 1 tablet | $0.078 | AB3 | Availability likely | — |
| Bupropion Hydrochloride XL 150 mg 82009-0051-05 | Quallent | 500 tablets | $0.078 | AB3 | Availability likely | — |
| Bupropion Hydrochloride (XL) 150 mg 83301-0024-01 | Mullan | 30 tablets | $0.078 | AB3 | Availability likely | — |
| Bupropion Hydrochloride 150 mg 16729-0443-10 | Accord | 30 tablets | $0.078 | AB3 | Availability likely | — |
| Bupropion hydrochloride 150 mg 63304-0723-05 | Sun | 500 tablets | $0.079 | — | Discontinued | — |
| Bupropion Hydrochloride XL 150 mg 42806-0348-05 | Epic | 500 tablets | $0.079 | AB3 | Availability likely | — |
| Bupropion Hydrochloride XL 150 mg 70436-0010-02 | Slate | 500 tablets | $0.079 | AB3 | Availability likely | — |
| Bupropion Hydrochloride 150 mg 59651-0847-01 | Aurobindo | 100 tablets | $0.080 | AB1 | Availability likely | — |
| Bupropion Hydrochloride SR 150 mg 00591-3541-05 | Actavis | 500 tablets | $0.080 | AB1 | Availability likely | — |
| Bupropion hydrochloride 150 mg 31722-0067-01 | Camber | 100 tablets | $0.080 | AB1 | Availability likely | — |
| Bupropion Hydrochloride SR 150 mg 42806-0425-01 | Epic | 100 tablets | $0.080 | AB1 | Availability likely | — |
| BuPROPion Hydrochloride 150 mg 68084-0708-25 | American | 1 tablet | $0.080 | AB1 | Availability likely | — |
| bupropion hydrochloride SR 150 mg 00904-7465-61 | Major | 1 tablet | $0.080 | AB1 | Availability likely | — |
| Bupropion Hydrochloride SR 150 mg 50228-0175-01 | ScieGen | 100 tablets | $0.080 | AB1 | Availability likely | — |
| Bupropion Hydrochloride SR 150 mg 43598-0752-01 | Dr. | 100 tablets | $0.080 | AB1 | Availability likely | — |
| Bupropion Hydrochloride 150 mg 42806-0415-01 | Epic | 100 tablets | $0.082 | AB1 | Availability likely | — |
| Bupropion Hydrochloride SR 150 mg 70436-0059-01 | Slate | 100 tablets | $0.084 | AB1 | FDA listed | — |
| Bupropion Hydrochloride (XL) 150 mg 43598-0655-05 | Dr | 500 tablets | $0.108 | AB3 | FDA listed | — |
| Bupropion Hydrochloride (XL) 150 mg 69097-0875-02 | CIPLA | 30 tablets | $0.119 | — | FDA listed | — |
| Bupropion hydrochloride (XL) 150 mg 00527-2415-32 | Lannett | 30 tablets | $0.119 | AB3 | FDA listed | — |
| Bupropion Hydrochloride SR 150 mg 00591-3543-60 | Actavis | 60 tablets | $0.252 | AB2 | Availability likely | — |
| Bupropion Hydrochloride SR 150 mg 42806-0413-60 | Epic | 60 tablets | $0.252 | AB2 | Availability likely | — |
| Bupropion Hydrochloride 150 mg 47335-0954-13 | Sun | 500 tablets | — | — | FDA listed | — |
| Bupropion Hydrochloride (SR) 150 mg 50228-0338-11 | ScieGen | 1000 tablets | — | AB2 | FDA listed | — |
| Bupropion hydrochloride 150 mg 63187-0052-30 | Proficient | 30 tablets | — | — | FDA listed | — |
| Bupropion Hydrochloride 150 mg 63187-0713-30 | Proficient | 30 tablets | — | — | FDA listed | — |
| Bupropion Hydrochloride SR 150 mg 63187-0726-30 | Proficient | 30 tablets | — | AB1 | FDA listed | — |
| Bupropion Hydrochloride (Sr) 150 mg 69097-0878-02 | Cipla | 30 tablets | — | — | FDA listed | — |
| Bupropion Hydrochloride XL 150 mg 71205-0291-30 | Proficient | 30 tablets | — | AB3 | FDA listed | — |
| Bupropion Hydrochloride XL 150 mg 71205-0394-30 | Proficient | 30 tablets | — | AB3 | FDA listed | — |
| Bupropion Hydrochloride 150 mg 71205-0504-30 | Proficient | 30 tablets | — | AB3 | FDA listed | — |
| bupropion 150 mg 71205-0565-30 | Proficient | 30 tablets | — | AB1 | FDA listed | — |
| Bupropion Hydrochloride (XL) 150 mg 71205-0967-30 | Proficient | 30 tablets | — | — | FDA listed | — |
| Bupropion Hydrochloride SR 150 mg 71610-0576-30 | Aphena | 30 tablets | — | AB1 | FDA listed | — |
| Bupropion Hydrochloride SR 150 mg 43598-0537-01 | Dr. | 100 tablets | — | AB1 | FDA listed | — |
| Bupropion Hydrochloride SR 150 mg 50090-1150-00 | A-S | 60 tablets | — | AB2 | FDA listed | — |
| Bupropion Hydrochloride XL 150 mg 50090-4049-00 | A-S | 90 tablets | — | AB3 | FDA listed | — |
| Bupropion Hydrochloride XL 150 mg 63187-0766-30 | Proficient | 30 tablets | — | AB3 | FDA listed | — |
| Bupropion Hydrochloride (XL) 150 mg 76282-0480-05 | Exelan | 500 tablets | — | — | FDA listed | — |
| Bupropion hydrochloride 150 mg 80425-0300-01 | Advanced | 30 tablets | — | AB3 | FDA listed | — |
| Bupropion Hydrochloride XL 150 mg 82804-0080-30 | Proficient | 30 tablets | — | AB3 | FDA listed | — |
| Bupropion Hydrochloride (XL) 150 mg 82868-0097-96 | Northwind | 180 tablets | — | AB3 | FDA listed | — |
| Wellbutrin Xl 150 mg 00187-0730-07 | Bausch | 7 tablets | — | AB3 | FDA listed | — |
| Bupropion Hydrochloride 150 mg 50090-5163-00 | A-S | 90 tablets | — | AB3 | FDA listed | — |
| Bupropion Hydrochloride (XL) 150 mg 50090-7110-00 | A-S | 90 tablets | — | — | FDA listed | — |
| bupropion 150 mg 51655-0357-26 | Northwind | 90 tablets | — | AB1 | FDA listed | — |
| Bupropion Hydrochloride XL 150 mg 68071-3594-03 | NuCare | 30 tablets | — | AB3 | FDA listed | — |
| bupropion hydrochloride 150 mg 70518-4674-00 | REMEDYREPACK | 30 tablets | — | AB3 | FDA listed | — |
| Bupropion Hydrochloride XL 150 mg 71335-2378-01 | Bryant | 30 tablets | — | AB3 | FDA listed | — |
| Bupropion Hydrochloride (Sr) 150 mg 43598-0863-10 | Dr. | 1000 tablets | — | AB2 | FDA listed | — |
| Bupropion Hydrochloride 150 mg 50090-4747-00 | A-S | 90 tablets | — | AB3 | FDA listed | — |
| Bupropion Hydrochloride SR 150 mg 50090-6871-00 | A-S | 60 tablets | — | AB1 | FDA listed | — |
| Bupropion Hydrochloride XL 150 mg 50090-7113-00 | A-S | 90 tablets | — | AB3 | Discontinued | — |
| Bupropion Hydrochloride 150 mg 50090-7712-00 | A-S | 90 tablets | — | AB3 | FDA listed | — |
| Bupropion Hydrochloride (XL) 150 mg 63629-8474-01 | Bryant | 30 tablets | — | AB3 | FDA listed | — |
| Bupropion hydrochloride 150 mg 70518-4081-01 | REMEDYREPACK | 30 tablets | — | AB1 | FDA listed | — |
| Bupropion hydrochloride 150 mg 70518-4189-00 | REMEDYREPACK | 30 tablets | — | AB3 | FDA listed | — |
| Bupropion hydrochloride 150 mg 71335-2457-01 | Bryant | 60 tablets | — | AB1 | FDA listed | — |
| Bupropion Hydrochloride SR 150 mg 71610-0990-30 | Aphena | 30 tablets | — | AB1 | FDA listed | — |
| Bupropion Hydrochloride (XL) 150 mg 72789-0120-90 | PD-Rx | 90 tablets | — | — | Discontinued | — |
| Bupropion Hydrochloride 150 mg 72789-0301-90 | PD-Rx | 90 tablets | — | AB3 | FDA listed | — |
| Bupropion Hydrochloride (XL) 150 mg 77771-0144-05 | RADHA | 500 tablets | — | AB3 | FDA listed | — |
| Bupropion Hydrochloride (XL) 150 mg 83008-0082-30 | Quality | 30 tablets | — | AB3 | FDA listed | — |
| bupropion hydrochloride SR 150 mg 55154-0183-00 | Cardinal | 1 tablet | — | AB1 | FDA listed | — |
| Bupropion hydrochloride 150 mg 68788-4010-01 | Preferred | 100 tablets | — | AB3 | FDA listed | — |
| Bupropion Hydrochloride 150 mg 68788-7786-01 | Preferred | 100 tablets | — | AB3 | FDA listed | — |
| Bupropion Hydrochloride (XL) 150 mg 70518-3963-00 | REMEDYREPACK | 30 tablets | — | AB3 | Discontinued | — |
| Bupropion Hydrochloride 150 mg 71335-1044-01 | Bryant | 30 tablets | — | AB3 | FDA listed | — |
| Bupropion Hydrochloride XL 150 mg 76420-0923-01 | Asclemed | 100 tablets | — | AB3 | FDA listed | — |
| Bupropion Hydrochloride (Sr) 150 mg 50090-5101-00 | A-S | 60 tablets | — | AB2 | FDA listed | — |
| Bupropion Hydrochloride (XL) 150 mg 50090-7109-00 | A-S | 90 tablets | — | — | FDA listed | — |
| Bupropion Hydrochloride 150 mg 50090-7711-00 | A-S | 90 tablets | — | AB3 | FDA listed | — |
| Bupropion Hydrochloride (XL) 150 mg 68071-3927-03 | NuCare | 30 tablets | — | AB3 | FDA listed | — |
| Bupropion Hydrochloride XL 150 mg 68071-3932-03 | NuCare | 30 tablets | — | AB3 | FDA listed | — |
| Bupropion Hydrochloride SR 150 mg 68788-7807-01 | Preferred | 100 tablets | — | AB1 | FDA listed | — |
| Bupropion Hydrochloride 150 mg 70010-0126-03 | Granules | 30 tablets | — | AB1 | FDA listed | — |
| Bupropion Hydrochloride 150 mg 70518-2458-00 | REMEDYREPACK | 90 tablets | — | AB3 | FDA listed | — |
| Bupropion Hydrochloride SR 150 mg 71335-1837-01 | Bryant | 60 tablets | — | AB1 | FDA listed | — |
| buPropion Hydrochloride XL 150 mg 72516-0035-03 | Oryza | 30 tablets | — | AB3 | FDA listed | — |
| Bupropion Hydrochloride 150 mg 80425-0461-01 | Advanced | 30 tablets | — | AB3 | FDA listed | — |
| bupropion hydrochloride SR 150 mg 43547-0289-06 | Solco | 60 tablets | — | AB1 | FDA listed | — |
| Bupropion hydrochloride 150 mg 50090-7423-00 | A-S | 90 tablets | — | AB1 | FDA listed | — |
| Bupropion Hydrochloride SR 150 mg 51655-0115-25 | Northwind | 60 tablets | — | AB1 | FDA listed | — |
| Bupropion Hydrochloride XL 150 mg 72789-0377-90 | PD-Rx | 90 tablets | — | AB3 | FDA listed | — |
| Bupropion Hydrochloride 150 mg 00615-8504-05 | NCS | 15 tablets | — | AB3 | FDA listed | — |
| Bupropion hydrochloride 150 mg 00615-8602-39 | NCS | 30 tablets | — | AB1 | FDA listed | — |
| Bupropion Hydrochloride 150 mg 00115-6811-02 | Amneal | 500 tablets | — | — | FDA listed | — |
| Bupropion Hydrochloride Sr 150 mg 43063-0744-30 | PD-Rx | 30 tablets | — | — | FDA listed | — |
| Bupropion Hydrochloride 150 mg 50090-6353-00 | A-S | 60 tablets | — | AB1 | FDA listed | — |
| Bupropion Hydrochloride XL 150 mg 51655-0098-26 | Northwind | 90 tablets | — | AB3 | FDA listed | — |
| Bupropion Hydrochloride XL 150 mg 67046-0699-03 | Coupler | 30 tablets | — | AB3 | FDA listed | — |
| Bupropion Hydrochloride SR 150 mg 71335-0135-01 | Bryant | 60 tablets | — | AB1 | FDA listed | — |
| Bupropion Hydrochloride 150 mg 72189-0134-30 | DIRECT | 30 tablets | — | AB3 | FDA listed | — |
| Bupropion Hydrochloride SR 150 mg 50090-6872-00 | A-S | 90 tablets | — | AB1 | FDA listed | — |
| Bupropion Hydrochloride SR 150 mg 63629-8473-01 | Bryant | 500 tablets | — | AB1 | FDA listed | — |
| Bupropion hydrochloride 150 mg 68788-8769-01 | Preferred | 100 tablets | — | AB1 | FDA listed | — |
| Bupropion hydrochloride 150 mg 71335-2469-01 | Bryant | 30 tablets | — | AB3 | FDA listed | — |
| Bupropion Hydrochloride 150 mg 50090-6789-00 | A-S | 90 tablets | — | AB3 | FDA listed | — |
| Bupropion hydrochloride (XL) 150 mg 69680-0157-30 | Vitruvias | 30 tablets | — | AB3 | FDA listed | — |
| Bupropion Hydrochloride 150 mg 70518-2022-02 | REMEDYREPACK | 90 tablets | — | AB3 | FDA listed | — |
| Bupropion Hydrochloride SR 150 mg 71335-1702-01 | Bryant | 60 tablets | — | AB1 | FDA listed | — |
| Bupropion Hydrochloride SR 150 mg 72162-1529-05 | Bryant | 500 tablets | — | AB1 | FDA listed | — |
| Bupropion Hydrochloride SR 150 mg 43063-0913-30 | PD-Rx | 30 tablets | — | AB1 | FDA listed | — |
| Bupropion Hydrochloride SR 150 mg 50090-7322-00 | A-S | 60 tablets | — | AB2 | Discontinued | — |
| Bupropion Hydrochloride (XL) 150 mg 72162-1526-05 | Bryant | 500 tablets | — | AB3 | FDA listed | — |
| Bupropion Hydrochloride SR 150 mg 77771-0175-05 | Radha | 500 tablets | — | AB1 | FDA listed | — |
| Bupropion hydrochloride 150 mg 82804-0296-90 | Proficient | 90 tablets | — | AB3 | FDA listed | — |
| Bupropion Hydrochloride SR 150 mg 82868-0019-60 | Northwind | 60 tablets | — | AB1 | FDA listed | — |
| Bupropion hydrochloride 150 mg 47335-0737-08 | Sun | 100 tablets | — | — | FDA listed | — |
| Bupropion Hydrochloride XL 150 mg 50090-7112-00 | A-S | 90 tablets | — | AB3 | Discontinued | — |
| Bupropion hydrochloride 150 mg 50090-7422-00 | A-S | 60 tablets | — | AB1 | FDA listed | — |
| Bupropion Hydrochloride SR 150 mg 68071-2890-03 | NuCare | 30 tablets | — | AB1 | FDA listed | — |
| Bupropion Hydrochloride 150 mg 68071-3559-09 | NuCare | 90 tablets | — | AB3 | FDA listed | — |
| Bupropion Hydrochloride SR 150 mg 70518-4056-01 | REMEDYREPACK | 30 tablets | — | AB1 | FDA listed | — |
| Bupropion Hydrochloride SR 150 mg 71205-0550-30 | Proficient | 30 tablets | — | AB1 | FDA listed | — |
| Bupropion hydrochloride 150 mg 67046-1273-03 | Coupler | 30 tablets | — | AB1 | FDA listed | — |
| bupropion hydrochloride 150 mg 71335-3153-01 | Bryant | 30 tablets | — | AB3 | FDA listed | — |
| Bupropion Hydrochloride 150 mg 59651-0511-05 | Aurobindo | 500 tablets | — | AB3 | FDA listed | — |
| Bupropion Hydrochloride (SR) 150 mgthis 33342-0527-10 | Macleods | 90 tablets | — | AB1 | FDA listed | — |
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
⏳ Availability & generic status
🏛️
2026
On the market since
Jun 2026
📍
2026
Currently FDA-listed
listed with the FDA
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug
This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
🔬 Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for BUPROPION HYDROCHLORIDE (SR) (this brand).
Top reported reactions
Age at onset
Reporter sex
Male · 31%
Female · 69%
Unknown · 0%
Serious outcomes
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
📦 Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Status |
|---|---|---|---|
| 33342-0527-10 You're viewing this | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (33342-527-10) | 2026-06-23 | Active |
| 33342-0527-11 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (33342-527-11) | 2026-06-23 | Active |
| 33342-0527-15 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (33342-527-15) | 2026-06-23 | Active |
You're viewing the smallest of 3 pack sizes for this product.
Pack size FAQ
What quantity is in NDC 33342-0527-10?
NDC 33342-0527-10 is a 90-count package — 90 tablet, extended release in 1 bottle.
What is the difference between NDC 33342-0527-10 and NDC 33342-0527-11?
Both are Bupropion Hydrochloride (SR) 150 mg Tablet, Extended Release — the drug itself is identical. NDC 33342-0527-10 is the 90-count package, while NDC 33342-0527-11 is the 100 tablets package.
What NDC number is used to bill for this package of Bupropion Hydrochloride (SR) 150 mg Tablet, Extended Release?
Bill NDC 33342-0527-10 — the 11-digit billing format is 33342052710. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.
🧭 About this NDC listing & data coverage
Finished prescription product
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | ✓ Available |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 33342-527-10, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 33342-0527-10, written without dashes as 33342052710. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 33342-0527-10, the first segment (33342) is the labeler code FDA assigned to Macleods Pharmaceuticals Limited; the middle segment (0527) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (10) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Macleods Pharmaceuticals Limited. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 2 other package presentations of this same product, including 100 tablets (33342-0527-11), 500 tablets (33342-0527-15). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Macleods Pharmaceuticals Limited is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as a prescription product, so it is dispensed under a prescriber's order. Your pharmacist can tell you whether any over-the-counter forms of the same medication exist.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
📄 Full prescribing information FDA SPL
The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 FDA label ▾
No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.